homocysteine has been researched along with Atherosclerotic Parkinsonism in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, P; Borah, A; Justin Thenmozhi, A; Manivasagam, T; Paul, R; Phukan, BC | 1 |
| Kaptsan, A; Lerner, V; Levine, J; Miodownik, C; Sela, BA; Vishne, T | 1 |
| Müller, T | 1 |
| Cadet, JL; Cutler, RG; Duan, W; Kruman, II; Ladenheim, B; Mattson, MP | 1 |
1 review(s) available for homocysteine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Role of homocysteine in the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Catechol O-Methyltransferase; Homocysteine; Humans; Levodopa; Parkinson Disease, Secondary | 2008 |
3 other study(ies) available for homocysteine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.
Topics: Animals; Antioxidants; Behavior, Animal; Catecholamines; Dopamine; Dopaminergic Neurons; Electron Transport Complex I; Free Radicals; Homocysteine; Male; Melatonin; Microinjections; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2018 |
High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Homocysteine; Humans; Israel; Male; Middle Aged; Parkinson Disease, Secondary; Prospective Studies; Psychotic Disorders; Regression Analysis; Risk Factors; Schizophrenia; Sex Factors | 2005 |
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biomarkers; Brain; Cell Survival; Corpus Striatum; Diet; Dopamine; Drug Synergism; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Iron; Male; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Neurons; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Rotenone; Tumor Cells, Cultured | 2002 |